Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction
Clinical trial NCT05984134 · COMPLETED
Trial details
- NCT number
- NCT05984134
- Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2023-05-26
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.